Mitochondria-Targeted Nanosystem Enhances Radio–Radiodynamic–Chemodynamic Therapy on Triple Negative Breast Cancer
ACS Applied Materials & Interfaces · 10.05.2023 · 15 (18) · 21941-21952
DOI: 10.1021/acsami.3c02361 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 26.04.2023. Verfasst von Jiangsheng Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Department, Peking University, Beijing 100191, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Peking University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Radiodynamic therapy (RDT), which produces 1O2 and other reactive oxygen species (ROS) in response to X-rays, can be used in conjunction with radiation therapy (RT) to drastically lower X-ray dosage and reduce radio resistance associated with conventional radiation treatment. However, radiation-radiodynamic therapy (RT-RDT) is still impotent in a hypoxic environment in solid tumors due to its oxygen-dependent nature. Chemodynamic therapy (CDT) can generate reactive oxygen species and O2 by decomposing H2O2 in hypoxic cells and thus potentiate RT-RDT to achieve synergy. Herein, we developed a multifunctional nanosystem, AuCu-Ce6-TPP (ACCT), for RT-RDT-CDT. Ce6 photosensitizers were conjugated to AuCu nanoparticles via Au-S bonds to realize radiodynamic sensitization. Cu can be oxidized by H2O2 and catalyze the degradation of H2O2 to generate •OH through the Fenton-like reaction to realize CDT. Meanwhile, the degradation byproduct oxygen can alleviate hypoxia while Au can consume glutathione to increase the oxidative stress. We then attached mercaptoethyl-triphenylphosphonium (TPP-SH) to the nanosystem, targeting ACCT to mitochondria (colocalization Pearson coefficient 0.98) to directly disrupt mitochondrial membranes and more efficiently induce apoptosis. We confirmed that ACCT efficiently generates 1O2 and •OH upon X-ray irradiation, resulting in strong anticancer efficacy in both normoxic and hypoxic 4T1 cells. The down-regulation of hypoxia-inducible factor 1α expression and reduction of intracellular H2O2 concentrations suggested that ACCT could significantly alleviate hypoxia in 4T1 cells. ACCT-enhanced RT-RDT-CDT can successfully shrink or remove tumors in radioresistant 4T1 tumor-bearing mice upon 4 Gy of X-ray irradiation. Our work thus presents a new strategy to treat radioresistant hypoxic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Engineering Department, Peking University, Beijing 100191, P. R. China.
- College of Future Technology, Peking University, Beijing 100091, P. R. China.
- Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, P. R. China.
- National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Peking University School and Hospital of Stom…
ORCID-Profile: Kuangda Lu
Förderung
- Peking University
- National Natural Science Foundation of China
Zitieren
APA
Li, J., You, Z., Zhai, S., Zhao, J., & Lu, K. (2023). Mitochondria-Targeted Nanosystem Enhances Radio–Radiodynamic–Chemodynamic Therapy on Triple Negative Breast Cancer. ACS Applied Materials & Interfaces, 15(18), 21941-21952. https://doi.org/10.1021/acsami.3c02361
Vancouver
Li J, You Z, Zhai S, Zhao J, Lu K. Mitochondria-Targeted Nanosystem Enhances Radio–Radiodynamic–Chemodynamic Therapy on Triple Negative Breast Cancer. ACS Applied Materials & Interfaces. 2023;15(18):21941-21952. doi:10.1021/acsami.3c02361
BibTeX
@article{Li2023,
author = {Li, Jiangsheng and You, Zhu and Zhai, Shiyi and Zhao, Junxuan and Lu, Kuangda},
title = {Mitochondria-Targeted Nanosystem Enhances Radio–Radiodynamic–Chemodynamic Therapy on Triple Negative Breast Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {18},
pages = {21941--21952},
doi = {10.1021/acsami.3c02361}
}
EUVIMED